Viewing StudyNCT00096083



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00096083
Status: COMPLETED
Last Update Posted: 2013-10-23
First Post: 2004-11-09

Brief Title: Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
Sponsor: Delcath Systems Inc
Organization: Delcath Systems Inc

Conditions & Keywords Data

Conditions:
Name
Cancer
Keywords:
Name View
advanced adult primary liver cancer View
localized unresectable adult primary liver cancer View
recurrent adult primary liver cancer View
liver metastases View
adenocarcinoma of the colon View
adenocarcinoma of the esophagus View
adenocarcinoma of the extrahepatic bile duct View
adenocarcinoma of the gallbladder View
adenocarcinoma of the pancreas View
adenocarcinoma of the rectum View
adenocarcinoma of the stomach View
carcinoma of the appendix View
recurrent gallbladder cancer View
unresectable gallbladder cancer View
recurrent colon cancer View
stage IV colon cancer View
recurrent esophageal cancer View
stage IV esophageal cancer View
recurrent extrahepatic bile duct cancer View
recurrent gastric cancer View
stage IV gastric cancer View
recurrent rectal cancer View
stage IV rectal cancer View
small intestine adenocarcinoma View
recurrent small intestine cancer View
recurrent islet cell carcinoma View
recurrent pheochromocytoma View
metastatic pheochromocytoma View
pulmonary carcinoid tumor View
thyroid gland medullary carcinoma View
metastatic gastrointestinal carcinoid tumor View
recurrent gastrointestinal carcinoid tumor View
recurrent pancreatic cancer View
insulinoma View
WDHA syndrome View
glucagonoma View
pancreatic polypeptide tumor View
somatostatinoma View
stage IV pancreatic cancer View
intraocular melanoma View
conjunctival melanoma View
iris melanoma View
recurrent melanoma View
stage IV melanoma View
unresectable extrahepatic bile duct cancer View